The Insurance-to-Cash-Pay Transition: How Physicians Are Building Regen Practices Without Reimbursement Dependence
The AMA estimates facility-based physician payment will decrease by approximately 7% in 2026 under the Medicare Physician Fee Schedule, while medical cost trends are projected at 8.5% for the year. That is a 15-plus point gap between what Medicare pays and what it costs to run a practice. Meanwhile, a physician who performs a single […]
How to Audit Your Regen Clinic Website in 60 Minutes (The Conversion, Compliance, and SEO Checklist)
If your regen clinic website gets 500 visits per month at a 1.5% consultation request rate, you are generating 7 to 8 inquiries per month. Optimize to the healthcare top-performer benchmark of 5%, and without spending a single additional dollar on traffic, you are generating 25 inquiries per month. That is the delta between a […]
What to Look for (and Watch Out For) When Hiring a Marketing Agency for Your Regen Clinic
A regen clinic owner spent $4,500 per month for eight months with a well-reviewed general digital marketing agency. During that time, their Google Ads account was permanently suspended. Three blog posts were flagged for FDA-risk language. The website ended up converting worse than the one they started with. They did not hire a fraudulent agency. […]
How to Do Keyword Research for a Regen Clinic Without Targeting Phrases That Trigger FDA Risk
The keywords most regenerative medicine clinics are chasing are exactly the ones they should avoid. Not because they are too competitive, though they are. Because targeting them creates legal risk that most marketers have never been told about. “Stem cell therapy near me” and “exosome treatment [city]” are not just hard keywords to rank for. […]
Why Google Keeps Rejecting Your Regen Clinic Ads in 2026 (And the Compliant Fix)
Approximately 58% of first-time healthcare ads are disapproved on initial submission, the highest rejection rate of any advertising vertical on Google. For regenerative medicine clinics, that number is effectively higher because Google’s “Speculative and Experimental Treatment” policy specifically names PRP, stem cell therapy, cellular therapies, and regenerative medicine. Most clinic owners spend weeks troubleshooting ad […]
Exosome Marketing in 2026: What You Can Say, What You Can’t, and Why It Matters
Exosomes are one of the most searched topics in regenerative medicine right now, and one of the most dangerous things a clinic can market. As of 2026, the FDA has issued more than 12 warning letters specifically targeting exosome product marketing. The FTC has permanently banned clinic operators from ever marketing stem cell and exosome […]
361 vs. 351: What Every Regen Clinic Marketer Needs to Understand Before Publishing Anything
Most regenerative medicine clinic owners think “361” means they are in the clear. It does not. Section 361 is a narrow exemption, not a free pass. And your own marketing copy can strip it away. The FDA does not just regulate what products you use. It reads what you say about them. One marketing claim […]
The Traffic Light Framework: What Regenerative Medicine Clinics Can (and Can’t) Say in Their Marketing
Most regenerative medicine clinic owners are stuck between two bad outcomes. They either say too much in their marketing and risk FDA or FTC enforcement, or they say nothing and lose patients to competitors who are marketing aggressively. The traffic light framework ends the guessing game. Red means never publish. Yellow means use it only […]
Why Your Regen Clinic’s Marketing Is One Word Away From an FDA Warning Letter
One word on your website can turn a thriving regenerative medicine practice into an enforcement target. In 2025, the FDA issued over 200 enforcement letters related to deceptive drug advertising, the highest annual total in nearly 25 years. Real clinics received real warning letters for marketing language on their websites and social media. The FTC […]
Google Ads for Regenerative Medicine: What You Can and Can’t Say in 2026
Google Ads has strict rules about advertising regenerative medicine services. Stem cell therapy, PRP, exosomes, and gene therapy are all classified as speculative and experimental treatments. Direct promotion is banned. But Google does allow two exceptions, including one for educational content that gives regenerative medicine clinics a real path to advertising. This guide covers what […]